The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial.

[1]  Michael E. Miller,et al.  Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.

[2]  Grant D. Huang,et al.  Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.

[3]  D. Simons-Morton,et al.  Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics , 2010, Diabetes Care.

[4]  O. Pedersen,et al.  Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.

[5]  S. Prato.  Megatrials in type 2 diabetes. From excitement to frustration? , 2009, Diabetologia.

[6]  Thomas E. Moritz,et al.  Observation on Renal Outcomes in the Veterans Affairs Diabetes Trial , 2011, Diabetes Care.

[7]  S. Schinner,et al.  Effects of Intensive Glucose Lowering in Type 2 Diabetes , 2009 .

[8]  F. Nuttall,et al.  Cardiovascular Events and Correlates in the Veterans Affairs Diabetes Feasibility Trial Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes , 1997 .

[9]  R. Holman,et al.  10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.

[10]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[11]  Robert J. Anderson,et al.  Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis , 2009, Diabetes.

[12]  Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report , 2009, Diabetes, obesity & metabolism.

[13]  R. Turner.  The U.K. Prospective Diabetes Study: A review , 1998, Diabetes Care.

[14]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[15]  C. Abraira,et al.  The association between metabolic control and prevalent macrovascular disease in Type 2 diabetes: the VA Cooperative Study in diabetes. , 2006, Journal of diabetes and its complications.

[16]  S. Schinner.  Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes , 2009 .

[17]  D. Reda,et al.  Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial. , 2003, Journal of diabetes and its complications.

[18]  Robert J. Anderson,et al.  Increased plasma basic fibroblast growth factor is associated with coronary heart disease in adult type 2 diabetes mellitus. , 2011, Metabolism: clinical and experimental.

[19]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[20]  Robert J. Anderson,et al.  Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial , 2010, Diabetes Care.

[21]  Diederick Grobbee,et al.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.

[22]  N. Wong,et al.  Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial). , 2006, The American journal of cardiology.